Urinary Incontinence

Pathophysiology of Nocturnal Enuresis Explored in Adult Women

Publish Date September 21, 2022

Risk factors for NE severity included incontinence symptoms, poor flow, increased bladder sensation, detrusor overactivity and underactivity

Self-Cut Mesh Noninferior to Mesh Kits for Pelvic Organ Prolapse

Publish Date September 20, 2022

The US Food and Drug Administration ordered manufacturers of transvaginal mesh kits to discontinue sales and distribution in 2019.

Urinary Incontinence Risk Linked to Thigh Muscle Area in Older Women

Publish Date September 12, 2022

Investigators identified the association among community-dwelling adults aged 60 years or older enrolled in the Baltimore Longitudinal Study of Aging.

BTX-A Safe, Effective for Overactive Bladder in Older Adults

Publish Date September 9, 2022

A study of patients older than 70 years who had overactive bladder found that the vast major of them reported improvement urinary incontinence, urinary urgency, daytime urinary frequency, and nighttime frequency after intradetrusor injection of onabotulinumtoxinA.

Age-Related Overactive Bladder Linked to Metabolic Imbalance

Publish Date September 8, 2022

BDNF proteolysis imbalance may be a potential biomarker and therapeutic target, new findings suggest.

Vaginal Delivery Ups Risk for SUI, Pelvic Organ Prolapse Surgery

Publish Date September 7, 2022

The risk for these surgeries was negligible among never-pregnant women.

Prasterone Studied for Treatment of Urinary Urge Incontinence

Publish Date August 11, 2022

Observational study suggests symptoms of urinary urge incontinence reduced in postmenopausal women using prasterone

Urinary Incontinence Poses Burden to Long-Term Care

Publish Date July 29, 2022

Survey of nursing directors shows impact on residents, staff, including turnover

Clinicians Laud Nocturnal Polyuria Study

Publish Date July 14, 2022

Investigators comment on the first US-based prevalence study of nocturnal polyuria that collected frequency volume diary data in a non-clinic population.

J&J to Pay More Than $300 Million in Pelvic Mesh Case

Publish Date April 25, 2022

Patients claim implanted mesh caused them pain, bleeding, infections, and required surgical removal